Skip to navigation Skip to content
  • Woodruff
  • Business
  • Health Sciences
  • Law
  • MARBL
  • Oxford College
  • Theology
  • Schools
    • Undergraduate

      • Emory College
      • Oxford College
      • Business School
      • School of Nursing

      Community

      • Emory College
      • Oxford College
      • Business School
      • School of Nursing
    • Graduate

      • Business School
      • Graduate School
      • School of Law
      • School of Medicine
      • School of Nursing
      • School of Public Health
      • School of Theology
  • Libraries
    • Libraries

      • Robert W. Woodruff
      • Business
      • Chemistry
      • Health Sciences
      • Law
      • MARBL
      • Music & Media
      • Oxford College
      • Theology
    • Library Tools

      • Course Reserves
      • Databases
      • Digital Scholarship (ECDS)
      • discoverE
      • eJournals
      • Electronic Dissertations
      • EmoryFindingAids
      • EUCLID
      • ILLiad
      • OpenEmory
      • Research Guides
  • Resources
    • Resources

      • Administrative Offices
      • Emory Healthcare
      • Academic Calendars
      • Bookstore
      • Campus Maps
      • Shuttles and Parking
      • Athletics: Emory Eagles
      • Arts at Emory
      • Michael C. Carlos Museum
      • Emory News Center
      • Emory Report
    • Resources

      • Emergency Contacts
      • Information Technology (IT)
      • Outlook Web Access
      • Office 365
      • Blackboard
      • OPUS
      • PeopleSoft Financials: Compass
      • Careers
      • Human Resources
      • Emory Alumni Association
  • Browse
    • Works by Author
    • Works by Journal
    • Works by Subject
    • Works by Dept
    • Faculty by Dept
  • For Authors
    • How to Submit
    • Deposit Advice
    • Author Rights
    • Publishing Your Data
    • FAQ
    • Emory Open Access Policy
    • Open Access Fund
  • About OpenEmory
    • About OpenEmory
    • About Us
    • Citing Articles
    • Contact Us
    • Privacy Policy
    • Terms of Use
 
Contact Us

Filter Results:

Year

  • 2019 (3)
  • 2015 (2)
  • 2016 (2)
  • 2013 (1)
  • 2014 (1)
  • 2017 (1)
  • 2020 (1)

Author

  • Cummings, Richard (4)
  • Chen, Guangping (3)
  • Heimburg-Molinaro, Jamie (2)
  • Sands, Jeff (2)
  • Smith, David (2)
  • Song, Xiang (2)
  • Ahmed, Rafi (1)
  • Alemozaffar, Mehrdad (1)
  • Alli, Abdel A. (1)
  • Antonopoulos, Aristotelis (1)
  • Ban, Dongjo (1)
  • Bern, Marshall (1)
  • Birendra, KC (1)
  • Birmingham, Katherine G. (1)
  • Bochner, Bruce S. (1)
  • Bournazos, Stylianos (1)
  • Brand, Randall (1)
  • Brummet, Mary E. (1)
  • Byrd-Leotis, Lauren (1)
  • Byrd-Leotis, Lauren (1)
  • Cummings, Sandra F. (1)
  • Davis, Carl (1)
  • Dell, Anne (1)
  • Duong, Duc M. (1)
  • Edwards, Erin E. (1)
  • Ensink, Elliot (1)
  • Gao, Chao (1)
  • Guo, Zhengyu (1)
  • Haab, Brian B. (1)
  • Haslam, Stuart M. (1)
  • Hostetter, Galen (1)
  • Hou, Ruida (1)
  • Hsueh, Peter (1)
  • Hughey, Rebecca P. (1)
  • Ilori, Titilayo (1)
  • Jia, Nan (1)
  • Ju, Tongzhong (1)
  • Kiwamoto, Takumi (1)
  • Klein, Janet (1)
  • Kletter, Doron (1)
  • Kong, Xiangbo (1)
  • Krammer, Florian (1)
  • Kudelka, MR (1)
  • Kudelka, Matthew R. (1)
  • Li, Cong-jun (1)
  • Li, Xuechen (1)
  • Maamary, Jad (1)
  • Marcus, Adam (1)
  • McDonald, John (1)
  • McQuillan, Alyssa M. (1)
  • Mehta, Akul Y. (1)
  • Mehta, Anand S. (1)
  • Melcher, Karsten (1)
  • Motari, Mary G. (1)
  • Mouw, Janna (1)
  • Neish, Andrew (1)
  • O'Melia, Meghan J. (1)
  • Pal, Kuntal (1)
  • Palese, Peter (1)
  • Partyka, Katie (1)
  • Qian, Xiaoqian (1)
  • Qian, Xiaoqian (1)
  • Ravetch, Jeffrey V. (1)
  • Schlesinger, Sarah J. (1)
  • Schnaar, Ronald L. (1)
  • Seyfried, Nicholas (1)
  • Singh, Sudhir (1)
  • Song, Xuezheng (1)
  • Steinhauer, David (1)
  • Stowell, Sean (1)
  • Tan, Gene S. (1)
  • Tang, Huiyan (1)
  • Thomas, Susan N. (1)
  • Trost, Jessica (1)
  • Wang, Taia T. (1)
  • Wang, Yingchun (1)
  • Wu, Fan (1)
  • Xu, H. Eric (1)
  • Yadav, Jessica (1)
  • Yang, Baoxue (1)
  • Yu, Peng (1)
  • Zhu, Zhou (1)

Subject

  • Biology, Microbiology (4)
  • Health Sciences, Immunology (4)
  • Biology, Cell (3)
  • Chemistry, Biochemistry (3)
  • Health Sciences, Oncology (2)
  • Biology, Molecular (1)
  • Biology, Physiology (1)
  • Computer Science (1)
  • Health Sciences, Medicine and Surgery (1)

Journal

  • ADVANCED BIOSYSTEMS (1)
  • Cell (1)
  • FASEB Journal (1)
  • Frontiers in Molecular Biosciences (1)
  • Frontiers in Physiology (1)
  • Journal of Allergy and Clinical Immunology (1)
  • Journal of Proteome Research (1)
  • Journal of Virology (1)
  • NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (1)
  • Nature Methods (1)
  • Pflügers Archiv European Journal of Physiology (1)

Keyword

  • scienc (8)
  • technolog (8)
  • biomedicin (7)
  • life (7)
  • cell (5)
  • express (5)
  • lewi (5)
  • x (5)
  • antigen (4)
  • glycan (4)
  • biochemistri (3)
  • biolog (3)
  • cancer (3)
  • function (3)
  • molecular (3)
  • protein (3)
  • antibodi (2)
  • bind (2)
  • biochem (2)
  • c (2)
  • carbohydr (2)
  • concentr (2)
  • diseas (2)
  • fc (2)
  • fucosyl (2)
  • gene (2)
  • glycom (2)
  • glycosyl (2)
  • lectin (2)
  • ligand (2)
  • mechan (2)
  • membran (2)
  • method (2)
  • phosphoryl (2)
  • receptor (2)
  • research (2)
  • sialyllewisx (2)
  • transport (2)
  • tumor (2)
  • urea (2)
  • 1 (1)
  • 19 (1)
  • 199 (1)
  • 2 (1)
  • 3 (1)
  • 44 (1)
  • 5 (1)
  • 6 (1)
  • 9 (1)
  • a (1)
  • abo (1)
  • ac (1)
  • accumul (1)
  • acetyl (1)
  • acid (1)
  • activ (1)
  • adenocarcinoma (1)
  • adhes (1)
  • allergi (1)
  • amplif (1)
  • antibodylectin (1)
  • antiinflammatori (1)
  • apoptosi (1)
  • array (1)
  • arthriti (1)
  • asthma (1)
  • b (1)
  • biomark (1)
  • biomateri (1)
  • blood (1)
  • bloodgroup (1)
  • bowel (1)
  • ca (1)
  • cd (1)
  • cftr (1)
  • channel (1)
  • coliti (1)
  • collect (1)
  • colon (1)
  • cosmc (1)
  • ctype (1)
  • d (1)
  • defect (1)
  • diabet (1)
  • drift (1)
  • duct (1)
  • e (1)
  • effector (1)
  • eosinophil (1)
  • eselectin (1)
  • f (1)
  • fcgammariii (1)
  • fcreceptor (1)
  • fucos (1)
  • gal (1)
  • gamma (1)
  • gastroenterolog (1)
  • gc (1)
  • globular (1)

Author department

  • Biochem: Admin (6)
  • Medicine: Nephrology (3)
  • Physiology: Admin (3)
  • Micro/Immun: Admin (2)
  • Cell Biology: Admin (1)
  • EVP Health Affairs (1)
  • Pathology: Admin (1)
  • Peds: HemThrom (1)
  • Urology: Admin (1)

Search Results for all work with filters:

  • sialyl

Work 1-10 of 11

Sorted by relevance
  1. 1
  2. 2
>

Article

Natural and Synthetic Sialylated Glycan Microarrays and Their Applications

by Alyssa M. McQuillan; Lauren Byrd-Leotis; Jamie Heimburg-Molinaro; Richard Cummings

2019

Subjects
  • Biology, Molecular
  • Health Sciences, Immunology
  • Chemistry, Biochemistry
  • File Download
  • View Abstract

Abstract:Close

This focused chapter serves as a short survey of glycan microarrays that are available with sialylated glycans, including both defined and shotgun arrays, their generation, and their utility in studying differential binding interactions to sialylated compounds, highlighting N-glycolyl (Gc) modified sialylated compounds. A brief discussion of binding interactions by lectins, antibodies, and viruses, and their relevance that have been observed with sialylated glycan microarrays is presented, as well as a discussion of cross-comparisons of array platforms and efforts to centralize and standardize the glycan microarray data.

Article

Upregulation of Glycans Containing 3 ' Fucose in a Subset of Pancreatic Cancers Uncovered Using Fusion-Tagged Lectins

by Sudhir Singh; Kuntal Pal; Jessica Yadav; Huiyan Tang; Katie Partyka; Doron Kletter; Peter Hsueh; Elliot Ensink; KC Birendra; Galen Hostetter; H. Eric Xu; Marshall Bern; David Smith; Anand S. Mehta; Randall Brand; Karsten Melcher; Brian B. Haab

2015

Subjects
  • Chemistry, Biochemistry
  • File Download
  • View Abstract

Abstract:Close

The fucose post-translational modification is frequently increased in pancreatic cancer, thus forming the basis for promising biomarkers, but a subset of pancreatic cancer patients does not elevate the known fucose-containing biomarkers. We hypothesized that such patients elevate glycan motifs with fucose in linkages and contexts different from the known fucose-containing biomarkers. We used a database of glycan array data to identify the lectins CCL2 to detect glycan motifs with fucose in a 3′ linkage; CGL2 for motifs with fucose in a 2′ linkage; and RSL for fucose in all linkages. We used several practical methods to test the lectins and determine the optimal mode of detection, and we then tested whether the lectins detected glycans in pancreatic cancer patients who did not elevate the sialyl-Lewis A glycan, which is upregulated in ∼75% of pancreatic adenocarcinomas. Patients who did not upregulate sialyl-Lewis A, which contains fucose in a 4′ linkage, tended to upregulate fucose in a 3′ linkage, as detected by CCL2, but they did not upregulate total fucose or fucose in a 2′ linkage. CCL2 binding was high in cancerous epithelia from pancreatic tumors, including areas negative for sialyl-Lewis A and a related motif containing 3′ fucose, sialyl-Lewis X. Thus, glycans containing 3′ fucose may complement sialyl-Lewis A to contribute to improved detection of pancreatic cancer. Furthermore, the use of panels of recombinant lectins may uncover details about glycosylation that could be important for characterizing and detecting cancer.

Article

Mice deficient in the St3gal3 gene product alpha 2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation

by Takumi Kiwamoto; Mary E. Brummet; Fan Wu; Mary G. Motari; David Smith; Ronald L. Schnaar; Zhou Zhu; Bruce S. Bochner

2014

Subjects
  • Health Sciences, Immunology
  • Chemistry, Biochemistry
  • File Download
  • View Abstract

Abstract:Close

Background: Sialic acid-binding immunoglobulin-like lectin (Siglec)-F is a proapoptotic receptor on mouse eosinophils, but little is known about its natural tissue ligand. Objective: We previously reported that the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) is required for constitutive Siglec-F lung ligand synthesis. We therefore hypothesized that attenuation of ST3Gal-III will decrease Siglec-F ligand levels and enhance allergic eosinophilic airway inflammation. Methods: C57BL/6 wild-type mice and St3gal3 heterozygous or homozygous deficient (St3gal3+/- and St3gal3 -/-) mice were used. Eosinophilic airway inflammation was induced through sensitization to ovalbumin (OVA) and repeated airway OVA challenge. Siglec-F human IgG1 fusion protein (Siglec-F-Fc) was used to detect Siglec-F ligands. Lung tissue and bronchoalveolar lavage fluid (BALF) were analyzed for inflammation, as well as various cytokines and chemokines. Serum was analyzed for allergen-specific immunoglobulin levels. Results: Western blotting with Siglec-F-Fc detected approximately 500-kDa and approximately 200-kDa candidate Siglec-F ligands that were less abundant in St3gal3 +/- lung extracts and nearly absent in St3gal3-/- lung extracts. After OVA sensitization and challenge, Siglec-F ligands were increased in wild-type mouse lungs but less so in St3gal3 mutants, whereas peribronchial and BALF eosinophil numbers were greater in the mutants, with the following rank order: St3gal3-/- ≥ St3gal3+/- > wild-type mice. Levels of various cytokines and chemokines in BALF were not significantly different among these 3 types of mice, although OVA-specific serum IgG 1 levels were increased in St3gal3-/- mice. Conclusions: After OVA sensitization and challenge, St3gal3+/- and St3gal3 -/- mice have more intense allergic eosinophilic airway inflammation and less sialylated Siglec-F ligands in their airways. One possible explanation for these findings is that levels of sialylated airway ligands for Siglec-F might be diminished in mice with attenuated levels of ST3Gal-III, resulting in a reduction in a natural proapoptotic pathway for controlling airway eosinophilia.

Article

Cellular O-Glycome Reporter/Amplification to explore O-glycans of living cells

by Matthew R. Kudelka; Aristotelis Antonopoulos; Yingchun Wang; Duc M. Duong; Xuezheng Song; Nicholas Seyfried; Anne Dell; Stuart M. Haslam; Richard Cummings; Tongzhong Ju

2016

  • File Download
  • View Abstract

Abstract:Close

Protein O-glycosylation has key roles in many biological processes, but the repertoire of O-glycans synthesized by cells is difficult to determine. Here we describe an approach termed Cellular O-Glycome Reporter/Amplification (CORA), a sensitive method used to amplify and profile mucin-type O-glycans synthesized by living cells. Cells convert added peracetylated benzyl-α-N-acetylgalactosamine to a large variety of modified O-glycan derivatives that are secreted from cells, allowing for easy purification for analysis by HPLC and mass spectrometry (MS). Relative to conventional O-glycan analyses, CORA resulted in an ∼100-1,000-fold increase in sensitivity and identified a more complex repertoire of O-glycans in more than a dozen cell types from Homo sapiens and Mus musculus. Furthermore, when coupled with computational modeling, CORA can be used for predictions about the diversity of the human O-glycome and offers new opportunities to identify novel glycan biomarkers for human diseases.

Article

RNA-Seq analysis of glycosylation related gene expression in Streptozotocin-induced diabetic rat kidney inner medulla

by Xiaoqian Qian; Xuechen Li; Titilayo Ilori; Janet Klein; Rebecca P. Hughey; Cong-jun Li; Abdel A. Alli; Zhengyu Guo; Peng Yu; Xiang Song; Guangping Chen

2013

Subjects
  • Biology, Cell
  • Health Sciences, Medicine and Surgery
  • Computer Science
  • File Download
  • View Abstract

Abstract:Close

The UT-A1 urea transporter is crucial to the kidney's ability to generate concentrated urine. Native UT-A1 from kidney inner medulla (IM) is a heavily glycosylated protein with two glycosylation forms of 97 and 117 kDa. In diabetes, UT-A1 protein abundance, particularly the 117 kD isoform, is significantly increased corresponding to an increased urea permeability in perfused IM collecting ducts, which plays an important role in preventing the osmotic diuresis caused by glucosuria. However, how the glycan carbohydrate structure change and the glycan related enzymes regulate kidney urea transport activity, particularly under diabetic condition, is largely unknown. In this study, using sugar-specific binding lectins, we found that the carbohydrate structure of UT-A1 is changed with increased amounts of sialic acid, fucose, and increased glycan branching under diabetic conditions. These changes were accompanied by altered UT-A1 association with the galectin proteins, β-galactoside glycan binding proteins. To explore the molecular basis of the alterations of glycan structures, the highly sensitive next generation sequencing (NGS) technology, Illumina RNA-seq, was employed to analyze genes involved in the process of UT-A1 glycosylation using streptozotocin (STZ)—induced diabetic rat kidney. Differential gene expression analysis combining with quantitative PCR revealed that expression of a number of important glycosylation related genes were changed under diabetic conditions. These genes include the glycosyltransferase genes Mgat4a, the sialylation enzymes St3gal1 and St3gal4 and glycan binding protein galectin-3, -5, -8, and -9. In contrast, although highly expressed in kidney IM, the glycosyltransferase genes Mgat1, Mgat2, and fucosyltransferase Fut8, did not show any changes. Conclusions: In diabetes, not only is UT-A1 protein abundance increased but the protein's glycan structure is also significantly changed. UT-A1 protein becomes highly sialylated, fucosylated and branched. Consistently, a number of crucial glycosylation related genes are changed under diabetic conditions. The alteration of these genes may contribute to changes in the UT-A1 glycan structure and therefore modulate kidney urea transport activity and alleviate osmotic diuresis caused by glucosuria in diabetes.

Article

Identification of a Novel UT-B Urea Transporter in Human Urothelial Cancer

by Ruida Hou; Mehrdad Alemozaffar; Baoxue Yang; Jeff Sands; Xiangbo Kong; Guangping Chen

2017

Subjects
  • Biology, Microbiology
  • Health Sciences, Oncology
  • File Download
  • View Abstract

Abstract:Close

The urea transporter UT-B is widely expressed and has been studied in erythrocyte, kidney, brain and intestines. Interestingly, UT-B gene has been found more abundant in bladder than any other tissue. Recently, gene analyses demonstrate that SLC14A1 (UT-B) gene mutations are associated with bladder cancer, suggesting that urea transporter UT-B may play an important role in bladder carcinogenesis. In this study, we examined UT-B expression in bladder cancer with human primary bladder cancer tissues and cancer derived cell lines. Human UT-B has two isoforms. We found that normal bladder expresses long form of UT-B2 but was lost in 8 of 24 (33%) or significantly downregulated in 16 of 24 (67%) of primary bladder cancer patients. In contrast, the short form of UT-B1 lacking exon 3 was detected in 20 bladder cancer samples. Surprisingly, a 24-nt in-frame deletion in exon 4 in UT-B1 (UT-B1Δ24) was identified in 11 of 20 (55%) bladder tumors. This deletion caused a functional defect of UT-B1. Immunohistochemistry revealed that UT-B protein levels were significantly decreased in bladder cancers. Western blot analysis showed a weak UT-B band of 40 kDa in some tumors, consistent with UT-B1 gene expression detected by RT-PCR. Interestingly, bladder cancer associate UT-B1Δ24 was barely sialylated, reflecting impaired glycosylation of UT-B1 in bladder tumors. In conclusion, SLC14A1 gene and UT-B protein expression are significantly changed in bladder cancers. The aberrant UT-B expression may promote bladder cancer development or facilitate carcinogenesis induced by other carcinogens.

Article

Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy

by Taia T. Wang; Jad Maamary; Gene S. Tan; Stylianos Bournazos; Carl Davis; Florian Krammer; Sarah J. Schlesinger; Peter Palese; Rafi Ahmed; Jeffrey V. Ravetch

2015

Subjects
  • Biology, Cell
  • Biology, Microbiology
  • Health Sciences, Immunology
  • File Download
  • View Abstract

Abstract:Close

Protective vaccines elicit high-affinity, neutralizing antibodies by selection of somatically hypermutated B cell antigen receptors (BCR) on immune complexes (ICs). This implicates Fc-Fc receptor (FcR) interactions in affinity maturation, which, in turn, are determined by IgG subclass and Fc glycan composition within ICs. Trivalent influenza virus vaccination elicited regulation of anti-hemagglutinin (HA) IgG subclass and Fc glycans, with abundance of sialylated Fc glycans (sFc) predicting quality of vaccine response. We show that sFcs drive BCR affinity selection by binding the Type-II FcR CD23, thus upregulating the inhibitory FcγRIIB on activated B cells. This elevates the threshold requirement for BCR signaling, resulting in B cell selection for higher affinity BCR. Immunization with sFc HA ICs elicited protective, high-affinity IgGs against the conserved stalk of the HA. These results reveal a novel, endogenous pathway for affinity maturation that can be exploited for eliciting high-affinity, broadly neutralizing antibodies through immunization with sialylated immune complexes.

Article

Antigenic Pressure on H3N2 Influenza Virus Drift Strains Imposes Constraints on Binding to Sialylated Receptors but Not Phosphorylated Glycans

by Lauren Byrd-Leotis; Chao Gao; Nan Jia; Akul Y. Mehta; Jessica Trost; Sandra F. Cummings; Jamie Heimburg-Molinaro; Richard Cummings; David Steinhauer

2019

Subjects
  • Biology, Microbiology
  • Health Sciences, Immunology
  • File Download
  • View Abstract

Abstract:Close

H3N2 strains of influenza A virus emerged in humans in 1968 and have continued to circulate, evolving in response to human immune pressure. During this process of "antigenic drift," viruses have progressively lost the ability to agglutinate erythrocytes of various species and to replicate efficiently under the established conditions for amplifying clinical isolates and generating vaccine candidates. We have determined the glycome profiles of chicken and guinea pig erythrocytes to gain insights into reduced agglutination properties displayed by drifted strains and show that both chicken and guinea pig erythrocytes contain complex sialylated N-glycans but that they differ with respect to the extent of branching, core fucosylation, and the abundance of poly-N-acetyllactosamine (PL) [-3Galβ1-4GlcNAcβ1-]n structures. We also examined binding of the H3N2 viruses using three different glycan microarrays: The synthetic Consortium for Functional Glycomics array; the defined N-glycan array designed to reveal contributions to binding based on sialic acid linkage type, branched structures, and core modifications; and the human lung shotgun glycan microarray. The results demonstrate that H3N2 viruses have progressively lost their capacity to bind nearly all canonical sialylated receptors other than a selection of biantennary structures and PL structures with or without sialic acid. Significantly, all viruses displayed robust binding to nonsialylated high-mannose phosphorylated glycans, even as the recognition of sialylated structures is decreased through antigenic drift. IMPORTANCE Influenza subtype H3N2 viruses have circulated in humans for over 50 years, continuing to cause annual epidemics. Such viruses have undergone antigenic drift in response to immune pressure, reducing the protective effects of preexisting immunity to previously circulating H3N2 strains. The changes in hemagglutinin (HA) affiliated with drift have implications for the receptor binding properties of these viruses, affecting virus replication in the culture systems commonly used to generate and amplify vaccine strains. Therefore, the antigenic properties of the vaccines may not directly reflect those of the circulating strains from which they were derived, compromising vaccine efficacy. In order to reproducibly provide effective vaccines, it will be critical to understand the interrelationships between binding, antigenicity, and replication properties in different growth substrates.

Article

Modulation of kidney urea transporter UT-A3 activity by alpha2,6-sialylation

by Xiaoqian Qian; Jeff Sands; Xiang Song; Guangping Chen

2016

Subjects
  • Biology, Physiology
  • Biology, Cell
  • File Download
  • View Abstract

Abstract:Close

Two urea transporters, UT-A1 and UT-A3, are expressed in the kidney terminal inner medullary collecting duct (IMCD) and are important for the production of concentrated urine. UT-A1, as the largest isoform of all UT-A urea transporters, has gained much attention and been extensively studied; however, the role and the regulation of UT-A3 are less explored. In this study, we investigated UT-A3 regulation by glycosylation modification. A site-directed mutagenesis verified a single glycosylation site in UT-A3 at Asn279. Loss of the glycosylation reduced forskolin-stimulated UT-A3 cell membrane expression and urea transport activity. UT-A3 has two glycosylation forms, 45 and 65 kDa. Using sugar-specific binding lectins, the UT-A3 glycosylation profile was examined. The 45-kDa form was pulled down by lectin concanavalin A (Con A) and Galant husnivalis lectin (GNL), indicating an immature glycan with a high amount of mannose (Man), whereas the 65-kDa form is a mature glycan composed of acetylglucosamine (GlcNAc) and poly-N-acetyllactosame (poly-LacNAc) that was pulled down by wheat germ agglutinin (WGA) and tomato lectin, respectively. Interestingly, the mature form of UT-A3 glycan contains significant amounts of sialic acid. We explored the enzymes responsible for directing UT-A3 sialylation. Sialyltransferase ST6GalI, but not ST3GalIV, catabolizes UT-A3 α2,6-sialylation. Activation of protein kinase C (PKC) by PDB treatment promoted UT-A3 glycan sialylation and membrane surface expression. The PKC inhibitor chelerythrine blocks ST6GalI-induced UT-A3 sialylation. Increased sialylation by ST6GalI increased UT-A3 protein stability and urea transport activity. Collectively, our study reveals a novel mechanism of UT-A3 regulation by ST6GalI-mediated sialylation modification that may play an important role in kidney urea reabsorption and the urinary concentrating mechanism.

Article

Analyzing Mechanisms of Metastatic Cancer Cell Adhesive Phenotype Leveraging Preparative Adhesion Chromatography Microfluidic

by Katherine G. Birmingham; Meghan J. O'Melia; Dongjo Ban; Janna Mouw; Erin E. Edwards; Adam Marcus; John McDonald; Susan N. Thomas

2019

Subjects
  • Health Sciences, Oncology
  • Biology, Microbiology
  • File Download
  • View Abstract

Abstract:Close

An integrated, parallel-plate microfluidic device is engineered to interrogate and fractionate cells based on their adhesivity to a substrate surface functionalized with adhesive ligand in a tightly controlled flow environment to elucidate associated cell-intrinsic pathways. Wall shear stress levels and endothelial presentation of E-selectin are modeled after the inflamed vasculature microenvironment in order to simulate in vitro conditions under which in vivo hematogenous metastasis occurs. Based on elution time from the flow channel, the collection of separate fractions of cells—noninteracting and interacting—at high yields and viabilities enables multiple postperfusion analyses, including flow cytometry, in vivo metastasis modeling, and transcriptomic analysis. This platform enables the interrogation of flow-regulated cell molecular profiles, such as (co)expression levels of natively expressed selectin ligands sLex, CD44, and carcinoembryonic antigen, and cancer stem cell marker CD24. This additionally reveals E-selectin adhesivity exhibited by metastatic human colon carcinoma cells to be a transient phenotype. Facile and rapid, this methodology for unbiased, label free sorting of large populations of cells based on their adhesion in flow represents a method of studying flow-regulated adhesion in vitro for the identification of molecular drug targets for development as antimetastatic cancer therapeutics.
  1. 1
  2. 2
>
Site Statistics
  • 28,683
  • Total Works
  • 7,481,975
  • Downloads
  • 98,914
  • Downloads This Year
  • 6,807
  • Faculty Profiles

Copyright © 2016 Emory University - All Rights Reserved
540 Asbury Circle, Atlanta, GA 30322-2870
(404) 727-6861
Privacy Policy | Terms & Conditions

v2.2.8-dev

Contact Us Recent and Popular Items
Download now